Abstract:Objective To evaluate the safety and efficacy of transcatheter closure of post-surgery residual ventricular septal defect( VSD)and its mid-to long-term follow-up results. Methods The clinical data of patients with post-surgery residual VSD who underwent an attempt of percutaneous device closure from September 2002 to December 2013 in Childrenˊs Hospital of Fudan University were summarized. Results 21 patients( 11 males and 10 females ) with post-surgery residual VSD underwent an attempt of percutaneous device closure in our center. The mean age was 8. 8 years(2. 7-21 years)and the mean weight was 26. 3 kg(10. 5-53. 5 kg). Among these 21 patients,their previous surgery procedures were VSD repair in 13 cases,repair of tetralogy of Fallot( TOF)in 5 cases,repair of double outlet right ventricle( DORV)in 2 cases,and repair of complete transposition of great arteries( TGA)with VSD in 1 case. In addition,1 patient of post-TOF repair was associated with frequently premature ventricular contraction and ventricular tachycardia,2 patients of post VSD repair were associated with recoarctation of the aorta. The duration between previous surgery and transcathter device closure was 11-80 months. The mean diameter of VSDs in right ventricle( RV) side was 3. 73 mm(1. 6-6. 3 mm)by angiogram. There were multiple shunts in RV side in 4 patients,and one patient was left ventricle to right atrium shunt. The Qp/Qs ratio was 1. 53 ± 0. 23,and there was no pulmonary hypertension more than moderate. Amplatzer devices were successfully deployed in all cases except for 1 failure case due to a repeat complete block during the arterial-venous loop establishing,and 2 devices were used in 1 patient. The median device size was 6. 5 mm(4 -12 mm). A radio-frequency ablation and 2 balloon dilatations were successfully finished for the associated defects in the same procedure. There was no procedure-related adverse events. Mild residual shunt was showed by angiogram and transthoracic echocardiography( TTE ) immediate after closure in 3 patients. Three patients with moderate to severe tricuspid regurgitation before device closure improved significantly after closure. All patients were doing well clinically in a mean 22. 2 months(1 - 79 months)follow up. Minor arrhythmia was observed in 2 patients in the first year follow-up ECG including incomplete right bundle branch and first-degree atrioventricular block,and remained the same in another 6 months to 1 year follow-up. All 3 residual shunts disappeared in the follow-up echocardiography except for a 3. 4 mm residual shunt still existed in 1 patient with normal heart size and function. No new onset tricuspid or aortic regurgitation was showed. There was no device malposition or embolization,or thrombosis formation. Conclusion Transcatheter closure of post-surgery residual ventricular septal defect is safe,effective and less trauma. The mid-to long-term follow-up results of these cases are promising.

Initial experiences of transcatheter closure of postsurgical cardiac paravalvular leak

A new technique of managing paravalvular leak using a folding pericardium patch.

Transcatheter closure management of mitral paravalvular leakage: A single center experience

Safety and efficacy of transcatheter closure of paravalvular leakage: Clinical experience of 42 cases

Transcatheter Closure of Mitral Paravalvular Leak Via Multiple Approaches

Techniques and outcomes of paravalvular leak repair after transcatheter aortic valve replacement

Transbrachial Access for Transcatheter Closure of Paravalvular Leak Following Prosthetic Valve Replacement

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

[Feasibility and Efficacy of Percutaneous Closure of Paravalvuar Leak in Patients after Heart Valve Replacement Surgery Using Amplatzer Vascular Plug Ⅲ].

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Transcatheter Closure of a Paravalvular Leak Guided by Transesophageal Echocardiography and Three-Dimensional Printing

Transcatheter Paravalvular Leak Closure With Covered Stent Tract and Vascular Plug

Transcatheter closure of paravalvular leakage through multiple approaches after surgical mechanical valve replacements: A retrospective study

Complications of transcatheter paravalvular leak device closure of mitral valve: An updated review of the literature and a rare case presentation

TAVR-in-TAVR with a balloon-expandable valve for paravalvular leak

Evaluation of the therapeutic effect of interventional therapy of paravalvular leakage (PVL) after mitral and aortic valve replacement-7 cases

Clinical evaluation of transcatheter closure on pseudoaneurysm of perimembranous ventricular septum in intermediate term

[Effects of Transcatheter Closure of Perimembranous Ventricular Septal Defects: Intermediate and Long-Term Follow-Up of 68 Cases].

The efficacy and its mid-to long-term follow-up of transcathter closure of post-surgery residual ventricular septal defect of congenital heart disease

Transcatheter Device Closure of Perimembranous Ventricular Septal Defects: Mid-Term Outcomes.

Comparison of Transcatheter and Surgical Treatment of Paravalvular Leak: Results from a 5‐year Follow‐up Study